Industry partner Silicon Therapeutics’ innovative research uses MGHPCC facilities to host its computational physics platform advancing deep drug discovery and design.
Silicon Therapeutics, a fully integrated physics-driven drug discovery company, is one of several Massachusetts-based biotechnology companies now partnering with the MGHPCC to capitalize on the Center’s pre-eminent research computing facilities.
